KROS - Keros Therapeutics Inc
11.27
-0.310 -2.751%
Share volume: 625,841
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$11.58
-0.31
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-06-2024 | 02-26-2025 | 05-06-2025 | 11-05-2025 | 03-04-2026 | |
| Cash flow financing | 156.802 M | 3.531 M | 155.944 M | 75.544 M | 4.000 K | 140.000 K | -378.631 M | |
| Other financing cash flows | 5.721 M | 2.967 M | 1.008 M | 2.445 M | 4.000 K | 2.000 K | 127.000 K | |
| Cash flow | 111.296 M | -36.580 M | 125.058 M | 29.247 M | 160.610 M | 3.257 M | -406.057 M | |
| Net income | -43.114 M | -45.257 M | -52.956 M | -46.026 M | 148.451 M | -7.280 M | -23.461 M | |
| Depreciation | 277.000 K | 306.000 K | 314.000 K | 332.000 K | 344.000 K | 395.000 K | 400.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -946.000 K | -310.000 K | -386.000 K | -289.000 K | -565.000 K | -132.000 K | -134.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 946.000 K | 310.000 K | 386.000 K | 289.000 K | 565.000 K | 137.000 K | 134.000 K | |
| Cash Change | 111.296 M | -36.580 M | 125.058 M | 29.247 M | 160.610 M | 3.257 M | -406.057 M |